Showing papers in "Journal of Substance Abuse Treatment in 2019"

TL;DR: Most studies suggested telemedicine interventions were associated with high patient satisfaction and are an effective alternative, especially when access to treatment is otherwise limited, however, there were substantial methodological limitations to the research conducted to date.

TL;DR: Faster rates of opioid tapering were associated with a greater probability of adverse events and many patients discontinued opioids suddenly, with no dose reduction.

TL;DR: Individual review of buprenorphine and naltrexone studies showed these medications were either superior to methadone or to placebo, or were as effective as methamphetamineadone in reducing illicit opioid use post-release.

TL;DR: The PCARE program illustrates the potential for low-threshold buprenorphine treatment to engage populations who are justice-involved and largely disconnected from care and interventions that reduce risk for overdose and related harms.

TL;DR: Attenuation of policy-related barriers and adoption of appropriate buprenorphine use by the treatment community are critical tools in the continued effort to reduce the burdens associated with OUD.

TL;DR: The MITI 4.2.1 is a reliable instrument for measuring fidelity to Motivational Interviewing elements, also in the context of Community Reinforcement Approach Senior, however, in softening sustain talk, the rare measures, and persuade with permission it has proved more difficult to reach high levels of interrater reliability.

TL;DR: The results suggest that the synergistic implementation of the relational and technical components of MI is critical to facilitating a higher percentage of change talk.

TL;DR: Perceived barriers to effective treatment of OUD-associated endocarditis included the complexity of managing two life threatening illness simultaneously, external stigma towards individuals with OUD, and discontinuity in longitudinal care.

TL;DR: Patients reported positive experiences in a transitional, low threshold clinic for SUD, comparing it favorably to other programs, and almost universally appreciated the flexible and harm reduction-oriented model of treatment.

TL;DR: A high proportion of individuals with OUD and co-occurring mental illness are not receiving needed care, and nearly one in five of those with Oud but no diagnosed mental illness is receiving prescription medication for mental illness, suggesting that there is a need to better facilitate access to and coordinate behavioral health care across settings for individualswith OUD.

TL;DR: A high prevalence of HCV among opioid treatment program patients and the availability of effective treatments, uptake remains low and several key barriers and facilitators that can affect HCV treatment uptake are identified.

TL;DR: The current findings represent the best available summary analysis of group therapy for SUDs in adults in adults, however cautious interpretation is warranted given the limitations of the available data.

TL;DR: It was found that low to moderate health literacy levels were common for those attending residential substance abuse treatment and participants with lower health literacy tended to have poorer quality of life and mental health.

TL;DR: Integrated PTSD and substance use treatment which teaches extensive coping skills to promote external safety, symptom stabilisation, and emotional regulation may be particularly useful for women with more severe PTSD, or for those experiencing ongoing victimization for whom past-focused treatments are contraindicated.

TL;DR: Early results within the first six months indicate significantly shortened wait time for patients seeking treatment, provision of waiver training to 70 local physicians to prescribe buprenorphine, and improved knowledge and ability to provide patient care for providers participating in the first Project ECHO cohort.

TL;DR: Long-term based decision-making skills are important to commit to the complex and intensive treatment programs of therapeutic communities and the ability to withhold behavioural responses under positive affect is relevant to prevent relapse.

TL;DR: Opioid users seem likely to welcome greater choice and flexibility in respect of opioid agonist medications and appear more likely to accept and adhere to depot buprenorphine if it enables them to reduce their illicit drug use and facilitates their recovery.

TL;DR: Previous education/training regarding MAT is associated with more positive attitudes, suggesting that more awareness-raising or capacity building educational interventions are needed, especially for prosecutors and law enforcement personnel.

TL;DR: This study identified specific knowledge gaps, expectations, and priorities which are important for developing a decision aid for OUD treatment relevant to the target group.

TL;DR: Initial validation of the newly-developed Brief Opioid Stigma Scale is presented, showing that greater endorsement of the "harm" stigma subscale was associated with greater depressive symptoms, lower self-esteem, and poorer mental and physical functioning.

TL;DR: Findings support and expand previous evidence by showing that a CET protocol does not increase the effectiveness of a CBT intervention for smoking cessation among treatment-seeking smokers and reveals that CET may increase risk of relapse among nicotine-dependent individuals who successfully achieve abstinence.

TL;DR: Findings highlight the important role Medicaid has played in increasing insurance coverage for substance use disorder treatment and suggest restrictions in state Medicaid benefits and utilization policies were associated with a decreased percentage of Medicaid patients in treatment.

TL;DR: It is suggested that ETM deters additional detoxification episodes while the intervention is ongoing, but not after the intervention ends, which may help reduce repeated detoxifications.

TL;DR: It was found that fewer initial days of supply as well as a lower initial dose were associated with increased likelihood of treatment discontinuation, highlighting the importance of prescribing decisions when initiating buprenorphine for OUD.

TL;DR: The study indicated that the MoCA is a measure of cognitive impairment that is independent of psychological distress, as measured with the SCL-90-R, whereas the BRIEF-A Global Executive Composite is strongly associated with distress.

TL;DR: A needs assessment of community providers for Medication for Opioid Use Disorder in the EMergency department-initiated BuprenorphinE for opioid use Disorder trial network emphasized the need for increased availability and accessibility to MOUD on demand and protected communication channels between EDs and community providers of MouD.

TL;DR: Results are concerning because MMT remains the medication of choice for vulnerable patients with the most severe opioid use disorders, and for-profit providers treat a growing proportion of MMT patients.

TL;DR: It is illustrated that medication for opioid use disorders, as delivered in the H & S system in Vermont, is highly effective for reducing opioid use and overdose and improving functioning in many life domains.

TL;DR: This research presents an analysis of spatial access to both opioid use disorder treatment facilities and emergency medical services in New Hampshire during 2015-2016, a period during which there was a steep increase in unintentional overdoses involving fentanyl.

TL;DR: Effectiveness, ease of use, and positive views of the tested brief, self-administered positive psychology exercises render them promising tools to bolster happiness during treatment, which may have utility in supporting long-term recovery.